{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:35:50Z","timestamp":1786736150525,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Afr Med"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/aam.aam_48_18","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T02:35:22Z","timestamp":1565663722000},"page":"132","source":"Crossref","is-referenced-by-count":14,"title":["A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy"],"prefix":"10.4103","volume":"18","author":[{"given":"StephenOdunayo","family":"Ikuerowo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AlabaFredrich","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EmmanuelAjibola","family":"Jeje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NasiruAkanmu","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OlumuyiwaLouis","family":"Ojongbede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WasiuBamidele","family":"Mutiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OlufunmiladeAkinfolarin","family":"Omisanjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbimbolaAyodeji","family":"Abolarinwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1596-3519.264315-1","unstructured":"Cancer Facts and Statistics | American Cancer Society. Cancer.org; 2019. Available from: http:\/\/www.cancer.org\/acs\/groups\/content\/@epidemiologysurveilance\/documents\/document\/acspc-027766.pdf. [Last accessed on 2014 Apr 18]."},{"key":"key-10.4103\/1596-3519.264315-2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00345-012-0824-2","article-title":"Prostate cancer epidemiology in the United States","author":"Brawley","year":"2012","journal-title":"World J Urol"},{"key":"key-10.4103\/1596-3519.264315-3","first-page":"1340","article-title":"Prostate cancer in Nigerians: Facts and Nonfacts","author":"Osegbe","year":"1997","journal-title":"J Urol"},{"key":"key-10.4103\/1596-3519.264315-4","first-page":"34","article-title":"Prostate cancer in Port Harcourt, Nigeria: Features and outcome","author":"Eke","year":"2002","journal-title":"Niger J Surg Res","ISSN":"https:\/\/id.crossref.org\/issn\/1595-1103","issn-type":"print"},{"key":"key-10.4103\/1596-3519.264315-5","first-page":"280","article-title":"Cancer in Nigeria: A 10-year analysis of the Kano cancer registry","author":"Mohammed","year":"2008","journal-title":"Niger J Med"},{"key":"key-10.4103\/1596-3519.264315-6","first-page":"129","article-title":"Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination","author":"Ikuerowo","year":"2013","journal-title":"Pan Afr Med J"},{"key":"key-10.4103\/1596-3519.264315-7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1464-410x.2000.00576.x","article-title":"Antibiotic prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study","author":"Aron","year":"2000","journal-title":"BJU Int"},{"key":"key-10.4103\/1596-3519.264315-8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/502312","article-title":"Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon","author":"Otrock","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.4103\/1596-3519.264315-9","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: Data from SEER-medicare","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"key-10.4103\/1596-3519.264315-10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: Time to reassess antimicrobial prophylaxis?","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/1596-3519.264315-11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1464-410X.2011.10561.x","article-title":"Infection after transrectal ultrasonography-guided prostate biopsy: Increased relative risks after recent international travel or antibiotic use","author":"Patel","year":"2012","journal-title":"BJU Int"},{"key":"key-10.4103\/1596-3519.264315-12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.eururo.2011.12.058","article-title":"Infectious complications and hospital admissions after prostate biopsy in a European randomized trial","author":"Loeb","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/1596-3519.264315-13","first-page":"5135","article-title":"Multi-drug resistant E.coli urosepsis in physicians following transrectal ultrasound guided prostate biopsies \u2013 Three cases including one death","author":"Carlson","year":"2010","journal-title":"Can J Urol"},{"key":"key-10.4103\/1596-3519.264315-14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","article-title":"The incidence of fluoroquinolone resistant infections after prostate biopsy \u2013 Are fluoroquinolones still effective prophylaxis?","author":"Feliciano","year":"2008","journal-title":"J Urol"},{"key":"key-10.4103\/1596-3519.264315-15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1469-0691.2011.03638.x","article-title":"Fluoroquinolone-resistant E.coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy \u2013 Should we reassess our practices for antibiotic prophylaxis?","author":"Steensels","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key-10.4103\/1596-3519.264315-16","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","article-title":"Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care","author":"Taylor","year":"2012","journal-title":"J Urol"},{"key":"key-10.4103\/1596-3519.264315-17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer.Part 1: Screening, diagnosis, and local treatment with curative intent-update 2013","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"key-10.4103\/1596-3519.264315-18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.juro.2015.03.126","article-title":"A statewide intervention to reduce hospitalizations after prostate biopsy","author":"Womble","year":"2015","journal-title":"J Urol"},{"key":"key-10.4103\/1596-3519.264315-19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urology.2011.09.057","article-title":"Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates","author":"Duplessis","year":"2012","journal-title":"Urology"},{"key":"key-10.4103\/1596-3519.264315-20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.juro.2015.03.110","article-title":"Comparative effectiveness of targeted vs.empirical antibiotic prophylaxis to prevent sepsis from transrectal prostate biopsy: A Retrospective analysis","author":"Liss","year":"2015","journal-title":"J Urol"},{"key":"key-10.4103\/1596-3519.264315-21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.urology.2014.09.035","article-title":"Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: A cohort study","author":"Dai","year":"2015","journal-title":"Urology"},{"key":"key-10.4103\/1596-3519.264315-22","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00345-015-1571-y","article-title":"An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy","author":"Summers","year":"2015","journal-title":"World J Urol"},{"key":"key-10.4103\/1596-3519.264315-23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"key-10.4103\/1596-3519.264315-24","first-page":"5392107","article-title":"Prevalence, risk factors, and clinical relevance of fluoroquinolone-resistant organisms in rectal cultures: Should we target antibiotic prophylaxis prior to prostate biopsy?","author":"Van","year":"2016","journal-title":"Adv Urol"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:37:59Z","timestamp":1786732679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_48_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["264315"],"URL":"https:\/\/doi.org\/10.4103\/aam.aam_48_18","relation":{},"ISSN":["1596-3519"],"issn-type":[{"value":"1596-3519","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}